1. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials;Marchetti;Br J Cancer,2007
2. Food and Drug Administration. Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies. January 2006. Available from: URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078933.pdf.
3. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice;Kinders;Mol Interv,2007
4. Phase 0 (zero) clinical trials: more than zero benefit?;Schellens;Eur J Cancer,2009
5. European Medicine Agency. Guideline on strategies to identify and mitigate risks for first-in human clinical trials with investigational medicinal products. July 2007. Available from: URL: http://www.ema.europa.eu/pdfs/human/swp/2836707enfin.pdf.